Literature DB >> 16860045

Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Andrew M Kaunitz1, Paul D Miller, Valerie Montgomery Rice, Doug Ross, Michael R McClung.   

Abstract

INTRODUCTION: This 7-year, prospective, matched-cohort, clinical study evaluated the effects of intramuscular depot medroxyprogesterone acetate (DMPA) (150 mg/mL) on bone mineral density (BMD) in women aged 25-35 years.
METHODS: Bone mineral density changes in new DMPA-IM users (n=248) were compared with those in women using nonhormonal contraception (n=360) for up to 240 weeks of treatment and 96 weeks of posttreatment follow-up (in subjects receiving >or=1 dose).
RESULTS: At week 240 of treatment, mean percentage changes from baseline in DMPA-IM vs. nonhormonal subjects were: -5.16% (n=21) vs. +0.19% (n=65), total hip (p<.001); -5.38% (n=33) vs. +0.43% (n=105), lumbar spine (p<.001). At week 96 posttreatment, these values were: -0.20% (n=25) vs. +0.84% (n=43), total hip (p=.047); -1.19% (n=41) vs. +0.47% (n=66), lumbar spine (p=.017).
CONCLUSIONS: These results show BMD declines during DMPA-IM use; following discontinuation, significant increases in BMD occur through 96 weeks posttreatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860045     DOI: 10.1016/j.contraception.2006.03.010

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  18 in total

Review 1.  Effects of hypogonadism on bone metabolism in female adolescents and young adults.

Authors:  Madhusmita Misra
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

Review 2.  Medication-induced osteoporosis: screening and treatment strategies.

Authors:  Keshav Panday; Amitha Gona; Mary Beth Humphrey
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

Review 3.  Adverse bone effects of medications used to treat non-skeletal disorders.

Authors:  N B Watts
Journal:  Osteoporos Int       Date:  2017-07-27       Impact factor: 4.507

Review 4.  Contraception in women with medical problems.

Authors:  Mandish K Dhanjal
Journal:  Obstet Med       Date:  2008-12-01

5.  Factors associated with bone mineral density in healthy African women.

Authors:  Nyaradzo M Mgodi; Cliff Kelly; Brenda Gati; Susan Greenspan; James Y Dai; Vivian Bragg; Edward Livant; Jeanna M Piper; Clemensia Nakabiito; Tsitsi Magure; Jeanne M Marrazzo; Z Mike Chirenje; Sharon A Riddler
Journal:  Arch Osteoporos       Date:  2015-02-14       Impact factor: 2.617

Review 6.  Premenopausal Osteoporosis.

Authors:  Adi Cohen
Journal:  Endocrinol Metab Clin North Am       Date:  2016-11-24       Impact factor: 4.741

7.  Effect of injectable and oral contraceptives on serum lipids.

Authors:  Abbey B Berenson; Mahbubur Rahman; Gregg Wilkinson
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

8.  The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.

Authors:  I Kyvernitakis; K Kostev; T Nassour; F Thomasius; P Hadji
Journal:  Osteoporos Int       Date:  2016-07-26       Impact factor: 4.507

9.  Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users.

Authors:  Yen-Chi L Le; Mahbubur Rahman; Abbey B Berenson
Journal:  Obstet Gynecol       Date:  2009-08       Impact factor: 7.661

10.  Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.

Authors:  Mags E Beksinska; Immo Kleinschmidt; Jenni A Smit; Timothy M M Farley; Helen V Rees
Journal:  Contraception       Date:  2009-03-19       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.